Clinical Trials Directory

Trials / Completed

CompletedNCT04114669

Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)

Behavioral Economics Trial To Enhance Regulation of Blood Pressure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
401 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H ambulatory clinics as well as NYU Langone Family Health Centers, and will use a lottery incentive program to promote adherence to antihypertensive medication that will be delivered via smartphone for 6 months. The trial will randomize 435 patients with hypertension determined to have poor adherence (\<80% adherence with antihypertensive medication), in a 2:1 (intervention:control) ratio. Baseline enrollment will occur over 36 months with an expected 12 months follow-up per participant.

Conditions

Interventions

TypeNameDescription
BEHAVIORALControl Condition3 in-person study visits, approximately one hour each. These will take place at baseline, 6 months, and 12 months.
BEHAVIORALRegret LotteryDelivered by the Way to Health platform, installed on a smartphone and communicates with participants via text message.Participants are eligible to receive a potential cash reward if they are adherent with their antihypertensive medication the day before, which is monitored via electronic monitoring device (EMD) from AdhereTech. Each participant is assigned a 2-digit number for the trial, and each day the Way to Health platform randomly generates a 2-digit number. Participants will receive a prize if both digits match (1 in 100 chance) and will receive a prize of lesser value if one digit matches (18 in 100 chance). If they are not adherent with their medication, but would have won if they were adherent, they receive a text message that they would have won ("regret" component).

Timeline

Start date
2020-07-14
Primary completion
2025-05-12
Completion
2025-09-12
First posted
2019-10-03
Last updated
2025-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04114669. Inclusion in this directory is not an endorsement.